Vanderbilt University Medical Center (VUMC)


 

ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC

89 views
September 25, 2024
0 Comments
Login to view comments. Click here to Login